Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Genetics and Genomics›Peptide Mapping
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Peptide Mapping

Genetics and Genomics · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 6 min read

Analysis of peptides that are generated from the digestion or fragmentation of a protein or mixture of proteins, by electrophoresis; chromatography; or mass spectrometry.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (1,068 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Analysis of peptides that are generated from the digestion or fragmentation of a protein or mixture of proteins, by electrophoresis; chromatography; or mass spectrometry. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, genetic polymorphisms, patterns of gene expression, and patterns diagnostic for diseases.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Mapping, Peptide; Peptide Fingerprinting; Fingerprinting, Peptide; Protein Fingerprinting; Fingerprinting, Protein; Fingerprints, Peptide; Fingerprint, Peptide; Peptide Fingerprint.

Where it fits in the MeSH classification

Broader topics
Chromatography, Paper; Electrophoresis, Paper; Chemistry Techniques, Analytical; Sequence Analysis, Protein
Narrower topics
Protein Footprinting
See also
Peptide Fragments

Related concepts

  • Peptides
  • Proteins
  • Electrophoresis
  • Chromatography
  • Mass Spectrometry
  • Genetic Polymorphisms

Research landscape

PubMed indexes 11,971 records tagged with the MeSH heading “Peptide Mapping” (counts retrieved 2026-10-29). 312 of them (2.6%) were published from 2020 onward, and the busiest period so far is through 1999 with 6,048 records.

Reviews account for 385 records (3.2%) and meta-analyses for 1. Randomized controlled trials number 8 (0.1%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 6,048 records; 2000-2009: 3,621 records; 2010-2019: 1,990 records; 2020 onward: 312 records6,048through 19993,6212000-20091,9902010-20193122020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19996,048
2000-20093,621
2010-20191,990
2020 onward312
Share of records by publication typeReviews: 3.2 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.1 percentReviews3.2% (385)Meta-analyses0.0% (1)Randomized controlled trials0.1% (8)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 11,971 PubMed records
TypeRecordsShare
Reviews3853.2%
Meta-analyses10.0%
Randomized controlled trials80.1%

Method: PubMed query "Peptide Mapping"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in genetics and genomics

Genetic findings vary widely in strength. A variant linked to a condition in one study may not replicate in other ancestries, and most common variants have small effects that are meaningful only in aggregate. Studies of rare, high-impact variants can support strong causal claims about a gene, while association studies describe statistical links that need functional and independent replication. Check the sample size, the ancestry of participants, whether results were replicated, and whether a laboratory or clinical outcome was actually measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
A systematic evaluation of normalization methods in quantitative label-free proteomics
Välikangas T, Suomi T, Elo LL
2018Research article
Design not recorded in structured metadata
328cc by
PMID 27694351 · DOI · PMC5862339
PatternLab for proteomics: a tool for differential shotgun proteomics
Carvalho PC, Fischer JS, Chen EI, Yates JR, Barbosa VC
2008Research article
Design not recorded in structured metadata
115cc by
PMID 18644148 · DOI · PMC2488363
Development of an LC-MS/MS peptide mapping protocol for the NISTmAb
Mouchahoir T, Schiel JE
2018Research article
Design not recorded in structured metadata
108cc by
PMID 29411091 · DOI · PMC5830484
Quantifying Bone Collagen Fingerprint Variation Between Species
Baker A, Buckley M
2025Research article
Design not recorded in structured metadata
1cc by
PMID 39877940 · DOI · PMC11969642

A systematic evaluation of normalization methods in quantitative label-free proteomics [1]

Research article Välikangas T, Suomi T, Elo LL · · 2018 · cited 328 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
To date, mass spectrometry (MS) data remain inherently biased as a result of reasons ranging from sample handling to differences caused by the instrumentation.
Closing excerpt
Finally, we discuss the choice of a normalization method and some qualities of a suitable normalization method in the light of the results of our evaluation.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (241 words)

To date, mass spectrometry (MS) data remain inherently biased as a result of reasons ranging from sample handling to differences caused by the instrumentation. Normalization is the process that aims to account for the bias and make samples more comparable. The selection of a proper normalization method is a pivotal task for the reliability of the downstream analysis and results. Many normalization methods commonly used in proteomics have been adapted from the DNA microarray techniques. Previous studies comparing normalization methods in proteomics have focused mainly on intragroup variation. In this study, several popular and widely used normalization methods representing different strategies in normalization are evaluated using three spike-in and one experimental mouse label-free proteomic data sets. The normalization methods are evaluated in terms of their ability to reduce variation between technical replicates, their effect on differential expression analysis and their effect on the estimation of logarithmic fold changes. Additionally, we examined whether normalizing the whole data globally or in segments for the differential expression analysis has an effect on the performance of the normalization methods. We found that variance stabilization normalization (Vsn) reduced variation the most between technical replicates in all examined data sets. Vsn also performed consistently well in the differential expression analysis. Linear regression normalization and local regression normalization performed also systematically well. Finally, we discuss the choice of a normalization method and some qualities of a suitable normalization method in the light of the results of our evaluation.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 27694351 · DOI · PMC5862339

PatternLab for proteomics: a tool for differential shotgun proteomics [2]

Research article Carvalho PC, Fischer JS, Chen EI, Yates JR, Barbosa VC · · 2008 · cited 115 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundA goal of proteomics is to distinguish between states of a biological system by identifying protein expression differences.
Closing excerpt
com/patternlab.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (324 words)

BackgroundA goal of proteomics is to distinguish between states of a biological system by identifying protein expression differences. Liu et al. demonstrated a method to perform semi-relative protein quantitation in shotgun proteomics data by correlating the number of tandem mass spectra obtained for each protein, or "spectral count", with its abundance in a mixture; however, two issues have remained open: how to normalize spectral counting data and how to efficiently pinpoint differences between profiles. Moreover, Chen et al. recently showed how to increase the number of identified proteins in shotgun proteomics by analyzing samples with different MS-compatible detergents while performing proteolytic digestion. The latter introduced new challenges as seen from the data analysis perspective, since replicate readings are not acquired.ResultsTo address the open issues above, we present a program termed PatternLab for proteomics. This program implements existing strategies and adds two new methods to pinpoint differences in protein profiles. The first method, ACFold, addresses experiments with less than three replicates from each state or having assays acquired by different protocols as described by Chen et al. ACFold uses a combined criterion based on expression fold changes, the AC test, and the false-discovery rate, and can supply a "bird's-eye view" of differentially expressed proteins. The other method addresses experimental designs having multiple readings from each state and is referred to as nSVM (natural support vector machine) because of its roots in evolutionary computing and in statistical learning theory. Our observations suggest that nSVM's niche comprises projects that select a minimum set of proteins for classification purposes; for example, the development of an early detection kit for a given pathology. We demonstrate the effectiveness of each method on experimental data and confront them with existing strategies.ConclusionPatternLab offers an easy and unified access to a variety of feature selection and normalization strategies, each having its own niche. Additionally, graphing tools are available to aid in the analysis of high throughput experimental data. PatternLab is available at http://pcarvalho.com/patternlab.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 18644148 · DOI · PMC2488363

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb [3]

Research article Mouchahoir T, Schiel JE · · 2018 · cited 108 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Peptide mapping is a component of the analytical toolbox used within the biopharmaceutical industry to aid in the identity confirmation of a protein therapeutic and to monitor degradative events such as oxidation or deamidation.
Closing excerpt
Each peak was mapped to peptides identified using mass spectrometry data.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (258 words)

Peptide mapping is a component of the analytical toolbox used within the biopharmaceutical industry to aid in the identity confirmation of a protein therapeutic and to monitor degradative events such as oxidation or deamidation. These methods offer the advantage of providing site-specific information regarding post-translational and chemical modifications that may arise during production, processing or storage. A number of such variations may also be induced by the sample preparation methods themselves which may confound the ability to accurately evaluate the true modification levels. One important focus when developing a peptide mapping method should therefore be the use of sample preparation conditions that will minimize the degree of artificial modifications induced. Unfortunately, the conditions that are amenable to effective reduction, alkylation and digestion are often the same conditions that promote unwanted modifications. Here we describe the optimization of a tryptic digestion protocol used for peptide mapping of the NISTmAb IgG1κ which addresses the challenge of balancing maximum digestion efficiency with minimum artificial modifications. The parameters on which we focused include buffer concentration, digestion time and temperature, as well as the source and type of trypsin (recombinant vs. pancreatic; bovine vs porcine) used. Using the optimized protocol we generated a peptide map of the NISTmAb which allowed us to confirm its identity at the level of primary structure. Graphical abstract Peptide map of the NISTmAb RM 8671 monoclonal antibody. Tryptic digestion was performed using an optimized protocol and followed by LC-UV-MS analysis. The trace represents the total ion chromatogram. Each peak was mapped to peptides identified using mass spectrometry data.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29411091 · DOI · PMC5830484

Quantifying Bone Collagen Fingerprint Variation Between Species [4]

Research article Baker A, Buckley M · · 2025 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Collagen is the most ubiquitous protein in the animal kingdom and one of the most abundant proteins on Earth.
Closing excerpt
Furthermore, this multivariate statistical analysis demonstrates that PMFs in fish are substantively more distinct than those of mammalian or amphibian taxa.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (245 words)

Collagen is the most ubiquitous protein in the animal kingdom and one of the most abundant proteins on Earth. Despite having a relatively repetitive amino acid sequence motif that enables its triple helical structure, in type 1 collagen, that dominates skin and bone, there is enough variation for its increasing use for the biomolecular species identification of animal tissues processed or degraded beyond the amenability of DNA-based analyses. In recent years, this has been most commonly achieved through the technique of collagen peptide mass fingerprinting (PMF) known as ZooMS (Zooarchaeology by Mass Spectrometry), applied to the analysis of tens of thousands of samples across over one hundred studies in the past decade alone. However, a robust means to quantify variation between these fingerprints remains elusive, despite being increasingly required due to the shift towards a wider range of wild fauna and those that are more distantly related from currently known sequences. This is particularly problematic in fish due to their greater sequence variation. Here we evaluate the quantification of the relative closeness of collagen fingerprints between families using ANOSIM and a modified SIMPER analysis, incorporating relative peak intensity. Our results show a clear correlation between sequence differentiation and statistical distance of PMFs, indicating that the additional complexity of type 1 collagen in fish could directly affect the efficacy of biomolecular techniques such as ZooMS. Furthermore, this multivariate statistical analysis demonstrates that PMFs in fish are substantively more distinct than those of mammalian or amphibian taxa.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 39877940 · DOI · PMC11969642

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Mass spectrometry-based metabolomics [5]
    Dettmer K, Aronov PA, Hammock BD · Mass Spectrom Rev · 2007 · cited 1,362 times (Europe PMC)
  • Research article Protein biomarker discovery and validation: the long and uncertain path to clinical utility [6]
    Rifai N, Gillette MA, Carr SA · Nat Biotechnol · 2006 · cited 1,330 times (Europe PMC)
  • Research article Less label, more free: approaches in label-free quantitative mass spectrometry [7]
    Neilson KA, Ali NA, Muralidharan S, Mirzaei M, Mariani M, Assadourian G, et al. · Proteomics · 2011 · cited 523 times (Europe PMC)
  • Research article Proteomics: quantitative and physical mapping of cellular proteins [8]
    Blackstock WP, Weir MP · Trends Biotechnol · 1999 · cited 419 times (Europe PMC)
  • Research article Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation [9]
    Orlando V · Trends Biochem Sci · 2000 · cited 331 times (Europe PMC)
  • Research article Protein ligation: an enabling technology for the biophysical analysis of proteins [10]
    Muralidharan V, Muir TW · Nat Methods · 2006 · cited 261 times (Europe PMC)

References

  1. Välikangas T, Suomi T, Elo LL. A systematic evaluation of normalization methods in quantitative label-free proteomics. . 2018. PMID 27694351 · DOI · PMC5862339
  2. Carvalho PC, Fischer JS, Chen EI, Yates JR, Barbosa VC. PatternLab for proteomics: a tool for differential shotgun proteomics. . 2008. PMID 18644148 · DOI · PMC2488363
  3. Mouchahoir T, Schiel JE. Development of an LC-MS/MS peptide mapping protocol for the NISTmAb. . 2018. PMID 29411091 · DOI · PMC5830484
  4. Baker A, Buckley M. Quantifying Bone Collagen Fingerprint Variation Between Species. . 2025. PMID 39877940 · DOI · PMC11969642
  5. Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics. Mass Spectrom Rev. 2007. PMID 16921475 · DOI · PMC1904337
  6. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol. 2006. PMID 16900146 · DOI
  7. Neilson KA, Ali NA, Muralidharan S, Mirzaei M, Mariani M, Assadourian G, et al.. Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics. 2011. PMID 21243637 · DOI
  8. Blackstock WP, Weir MP. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 1999. PMID 10189717 · DOI
  9. Orlando V. Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends Biochem Sci. 2000. PMID 10694875 · DOI
  10. Muralidharan V, Muir TW. Protein ligation: an enabling technology for the biophysical analysis of proteins. Nat Methods. 2006. PMID 16721376 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Comet AssayGenetics and Genomics
  • Genome-Wide Association StudyGenetics and Genomics
  • Multilocus Sequence TypingGenetics and Genomics
  • Nanopore SequencingGenetics and Genomics
  • RNA-SeqGenetics and Genomics
  • Sequence AnalysisGenetics and Genomics

All 95 articles in Genetics and Genomics →

At a glance

11,971
PubMed records on this heading
3%
published since 2020
385
review articles
8
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Comet AssayGenetics and Genomics
  • Genome-Wide Association StudyGenetics and Genomics
  • Multilocus Sequence TypingGenetics and Genomics
  • Nanopore SequencingGenetics and Genomics
  • RNA-SeqGenetics and Genomics

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support